Search for a company
Rs. 65.90 B
+7.7% YoY · sector 15.6%
Rs. 10.03 B
+53.4% YoY · sector 45.0%
₨31.48
Sector growth 45.0%
29.8%
vs sector 23.5%
10.8x
vs sector 14.4x
5.0%
vs sector 2.6%
GlaxoSmithKline Pakistan Limited has shown positive revenue growth of 7.7% over the past year. Net income has grown by 53.4% year-over-year. The company maintains a return on equity of 7.2%.
GLAXO · PHARMACEUTICALS
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
GLAXO stock data provided by Ticker Analysts. Prices may be delayed. Data is for informational purposes only.